<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>XThe ODX Blog - Old/Original Blog (Do Not Use)</title>
    <link>https://5340373.hs-sites-na2.com/blog-old</link>
    <description>Blog | Optimal DX | Functional Blood Chemistry Analysis Software</description>
    <language>en</language>
    <pubDate>Tue, 07 Feb 2023 15:58:18 GMT</pubDate>
    <dc:date>2023-02-07T15:58:18Z</dc:date>
    <dc:language>en</dc:language>
    <item>
      <title>Andropause part 9 - Optimal Takeaways</title>
      <link>https://5340373.hs-sites-na2.com/blog-old/andropause-part-9-optimal-takeaways</link>
      <description>&lt;p&gt;Welcome to part 9 of the ODX Andropause &amp;amp; Low T Syndrome Series. In this final post in our series, we cover the Optimal Takeaways for the assessment and treatment of Andropause or Low T Syndrome&lt;/p&gt; 
&lt;p&gt;&lt;/p&gt;</description>
      <content:encoded>&lt;p&gt;Welcome to part 9 of the ODX Andropause &amp;amp; Low T Syndrome Series. In this final post in our series, we cover the Optimal Takeaways for the assessment and treatment of Andropause or Low T Syndrome&lt;/p&gt; 
&lt;p&gt;&lt;/p&gt;  
&lt;img src="https://track-na2.hubspot.com/__ptq.gif?a=5340373&amp;amp;k=14&amp;amp;r=https%3A%2F%2F5340373.hs-sites-na2.com%2Fblog-old%2Fandropause-part-9-optimal-takeaways&amp;amp;bu=https%253A%252F%252F5340373.hs-sites-na2.com%252Fblog-old&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <pubDate>Tue, 20 Jul 2021 23:52:28 GMT</pubDate>
      <guid>https://5340373.hs-sites-na2.com/blog-old/andropause-part-9-optimal-takeaways</guid>
      <dc:date>2021-07-20T23:52:28Z</dc:date>
      <dc:creator>ODX Research</dc:creator>
    </item>
    <item>
      <title>Andropause part 8 - Lifestyle Approaches to Addressing Andropause</title>
      <link>https://5340373.hs-sites-na2.com/blog-old/andropause-part-8-lifestyle-approaches</link>
      <description>&lt;p style="font-size: 10px;"&gt;Welcome to part 8 of the ODX Andropause &amp;amp; Low T Syndrome Series.Lifestyle factors play a role in the etiology and resolution of LOH, just as they play a role in some of the metabolic disorders that contribute to LO, including type 2 diabetes and obesity.[1]&lt;/p&gt; 
&lt;p style="font-size: 10px;"&gt;&lt;/p&gt;</description>
      <content:encoded>&lt;p style="font-size: 10px;"&gt;Welcome to part 8 of the ODX Andropause &amp;amp; Low T Syndrome Series.Lifestyle factors play a role in the etiology and resolution of LOH, just as they play a role in some of the metabolic disorders that contribute to LO, including type 2 diabetes and obesity.[1]&lt;/p&gt; 
&lt;p style="font-size: 10px;"&gt;&lt;/p&gt;  
&lt;img src="https://track-na2.hubspot.com/__ptq.gif?a=5340373&amp;amp;k=14&amp;amp;r=https%3A%2F%2F5340373.hs-sites-na2.com%2Fblog-old%2Fandropause-part-8-lifestyle-approaches&amp;amp;bu=https%253A%252F%252F5340373.hs-sites-na2.com%252Fblog-old&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <pubDate>Tue, 20 Jul 2021 23:50:25 GMT</pubDate>
      <guid>https://5340373.hs-sites-na2.com/blog-old/andropause-part-8-lifestyle-approaches</guid>
      <dc:date>2021-07-20T23:50:25Z</dc:date>
      <dc:creator>ODX Research</dc:creator>
    </item>
    <item>
      <title>Andropause part 7 - Treating &amp; Counteracting Andropause</title>
      <link>https://5340373.hs-sites-na2.com/blog-old/andropause-part-7-treatment</link>
      <description>&lt;p&gt;Welcome to part 7 of the ODX Andropause &amp;amp; Low T Syndrome Series. Once Andropause or Low T Syndrome and its causes have been identified, approaches to treatment include testosterone replacement therapy, non-hormonal natural medicine approaches, and lifestyle changes.&lt;/p&gt; 
&lt;p&gt;&lt;/p&gt;</description>
      <content:encoded>&lt;p&gt;Welcome to part 7 of the ODX Andropause &amp;amp; Low T Syndrome Series. Once Andropause or Low T Syndrome and its causes have been identified, approaches to treatment include testosterone replacement therapy, non-hormonal natural medicine approaches, and lifestyle changes.&lt;/p&gt; 
&lt;p&gt;&lt;/p&gt;  
&lt;img src="https://track-na2.hubspot.com/__ptq.gif?a=5340373&amp;amp;k=14&amp;amp;r=https%3A%2F%2F5340373.hs-sites-na2.com%2Fblog-old%2Fandropause-part-7-treatment&amp;amp;bu=https%253A%252F%252F5340373.hs-sites-na2.com%252Fblog-old&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <pubDate>Tue, 20 Jul 2021 23:40:30 GMT</pubDate>
      <guid>https://5340373.hs-sites-na2.com/blog-old/andropause-part-7-treatment</guid>
      <dc:date>2021-07-20T23:40:30Z</dc:date>
      <dc:creator>ODX Research</dc:creator>
    </item>
    <item>
      <title>Andropause part 6 - Lab Reference Ranges</title>
      <link>https://5340373.hs-sites-na2.com/blog-old/andropause-part-6-lab-reference-ranges</link>
      <description>&lt;p&gt;Welcome to part 6 of the ODX Andropause &amp;amp; Low T Syndrome Series. In this post, the ODX research team reviews the reference ranges for the most common male sex hormones: Total Testosterone, Free Testosterone, Bioavailable Testosterone, and Sex Hormone Binding Globulin. We will also review additional biomarkers that will give you a full picture of what’s going on.&lt;/p&gt; 
&lt;p&gt;&lt;/p&gt;</description>
      <content:encoded>&lt;p&gt;Welcome to part 6 of the ODX Andropause &amp;amp; Low T Syndrome Series. In this post, the ODX research team reviews the reference ranges for the most common male sex hormones: Total Testosterone, Free Testosterone, Bioavailable Testosterone, and Sex Hormone Binding Globulin. We will also review additional biomarkers that will give you a full picture of what’s going on.&lt;/p&gt; 
&lt;p&gt;&lt;/p&gt;  
&lt;img src="https://track-na2.hubspot.com/__ptq.gif?a=5340373&amp;amp;k=14&amp;amp;r=https%3A%2F%2F5340373.hs-sites-na2.com%2Fblog-old%2Fandropause-part-6-lab-reference-ranges&amp;amp;bu=https%253A%252F%252F5340373.hs-sites-na2.com%252Fblog-old&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <pubDate>Tue, 20 Jul 2021 23:40:26 GMT</pubDate>
      <guid>https://5340373.hs-sites-na2.com/blog-old/andropause-part-6-lab-reference-ranges</guid>
      <dc:date>2021-07-20T23:40:26Z</dc:date>
      <dc:creator>ODX Research</dc:creator>
    </item>
    <item>
      <title>Andropause part 5 - Clinical Determination</title>
      <link>https://5340373.hs-sites-na2.com/blog-old/andropause-part-5-clinical-determination</link>
      <description>&lt;p&gt;Welcome to part 5 of the ODX Andropause &amp;amp; Low T Syndrome Series. The clinical determination of andropause must take into consideration the patient’s symptomology and lab values of Total and Free testosterone. As you’ll read in this post, the Functional determination of low T syndrome takes a slightly different approach.&lt;/p&gt; 
&lt;p&gt;&lt;/p&gt;</description>
      <content:encoded>&lt;p&gt;Welcome to part 5 of the ODX Andropause &amp;amp; Low T Syndrome Series. The clinical determination of andropause must take into consideration the patient’s symptomology and lab values of Total and Free testosterone. As you’ll read in this post, the Functional determination of low T syndrome takes a slightly different approach.&lt;/p&gt; 
&lt;p&gt;&lt;/p&gt;  
&lt;img src="https://track-na2.hubspot.com/__ptq.gif?a=5340373&amp;amp;k=14&amp;amp;r=https%3A%2F%2F5340373.hs-sites-na2.com%2Fblog-old%2Fandropause-part-5-clinical-determination&amp;amp;bu=https%253A%252F%252F5340373.hs-sites-na2.com%252Fblog-old&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <pubDate>Tue, 20 Jul 2021 23:40:23 GMT</pubDate>
      <guid>https://5340373.hs-sites-na2.com/blog-old/andropause-part-5-clinical-determination</guid>
      <dc:date>2021-07-20T23:40:23Z</dc:date>
      <dc:creator>ODX Research</dc:creator>
    </item>
    <item>
      <title>Andropause part 4 - Lab Assessment &amp; Biomarker Guideposts</title>
      <link>https://5340373.hs-sites-na2.com/blog-old/andropause-part-4-lab-assessment-biomarkers</link>
      <description>&lt;p&gt;Welcome to part 4 of the ODX Andropause &amp;amp; Low T Syndrome Series. In this post, the ODX Research team reviews the best biomarkers to test and the ranges to use in order to get an accurate assessment and diagnosis of Andropause or Low T Syndrome.&lt;/p&gt; 
&lt;p&gt;&lt;/p&gt;</description>
      <content:encoded>&lt;p&gt;Welcome to part 4 of the ODX Andropause &amp;amp; Low T Syndrome Series. In this post, the ODX Research team reviews the best biomarkers to test and the ranges to use in order to get an accurate assessment and diagnosis of Andropause or Low T Syndrome.&lt;/p&gt; 
&lt;p&gt;&lt;/p&gt;  
&lt;img src="https://track-na2.hubspot.com/__ptq.gif?a=5340373&amp;amp;k=14&amp;amp;r=https%3A%2F%2F5340373.hs-sites-na2.com%2Fblog-old%2Fandropause-part-4-lab-assessment-biomarkers&amp;amp;bu=https%253A%252F%252F5340373.hs-sites-na2.com%252Fblog-old&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <pubDate>Tue, 20 Jul 2021 23:40:19 GMT</pubDate>
      <guid>https://5340373.hs-sites-na2.com/blog-old/andropause-part-4-lab-assessment-biomarkers</guid>
      <dc:date>2021-07-20T23:40:19Z</dc:date>
      <dc:creator>ODX Research</dc:creator>
    </item>
    <item>
      <title>Andropause part 3 - How Do We Identify It?</title>
      <link>https://5340373.hs-sites-na2.com/blog-old/andropause-part-3-identification-diagnosis</link>
      <description>&lt;p&gt;Welcome to part 3 of the ODX Andropause &amp;amp; Low T Syndrome Series. In this post, the ODX Research team reviews the best ways to approach the identification and diagnosis of Low T Syndrome and andropause.&lt;/p&gt; 
&lt;p&gt;&lt;/p&gt;</description>
      <content:encoded>&lt;p&gt;Welcome to part 3 of the ODX Andropause &amp;amp; Low T Syndrome Series. In this post, the ODX Research team reviews the best ways to approach the identification and diagnosis of Low T Syndrome and andropause.&lt;/p&gt; 
&lt;p&gt;&lt;/p&gt;  
&lt;img src="https://track-na2.hubspot.com/__ptq.gif?a=5340373&amp;amp;k=14&amp;amp;r=https%3A%2F%2F5340373.hs-sites-na2.com%2Fblog-old%2Fandropause-part-3-identification-diagnosis&amp;amp;bu=https%253A%252F%252F5340373.hs-sites-na2.com%252Fblog-old&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <pubDate>Tue, 20 Jul 2021 23:40:15 GMT</pubDate>
      <guid>https://5340373.hs-sites-na2.com/blog-old/andropause-part-3-identification-diagnosis</guid>
      <dc:date>2021-07-20T23:40:15Z</dc:date>
      <dc:creator>ODX Research</dc:creator>
    </item>
    <item>
      <title>Andropause part 2 - Biology &amp; Physiology</title>
      <link>https://5340373.hs-sites-na2.com/blog-old/andropause-part-2-biology-physiology</link>
      <description>&lt;p&gt;Welcome to part 2 of the ODX Andropause &amp;amp; Low T Syndrome Series. In this post, the ODX Research team reviews the biology and physiology of what lies beneath the hormonal change known as andropause and Low T Syndrome.&lt;/p&gt; 
&lt;p&gt;&lt;/p&gt;</description>
      <content:encoded>&lt;p&gt;Welcome to part 2 of the ODX Andropause &amp;amp; Low T Syndrome Series. In this post, the ODX Research team reviews the biology and physiology of what lies beneath the hormonal change known as andropause and Low T Syndrome.&lt;/p&gt; 
&lt;p&gt;&lt;/p&gt;  
&lt;img src="https://track-na2.hubspot.com/__ptq.gif?a=5340373&amp;amp;k=14&amp;amp;r=https%3A%2F%2F5340373.hs-sites-na2.com%2Fblog-old%2Fandropause-part-2-biology-physiology&amp;amp;bu=https%253A%252F%252F5340373.hs-sites-na2.com%252Fblog-old&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <pubDate>Tue, 20 Jul 2021 23:40:09 GMT</pubDate>
      <guid>https://5340373.hs-sites-na2.com/blog-old/andropause-part-2-biology-physiology</guid>
      <dc:date>2021-07-20T23:40:09Z</dc:date>
      <dc:creator>ODX Research</dc:creator>
    </item>
    <item>
      <title>Andropause part 1 - An Introduction</title>
      <link>https://5340373.hs-sites-na2.com/blog-old/andropause-part-1-an-introduction</link>
      <description>&lt;p&gt;Welcome to the ODX Andropause &amp;amp; Low T Syndrome Series. In this series of posts, the ODX Research team dives into Testosterone with an exploration of andropause and Low T Syndrome in our male patients.&lt;/p&gt; 
&lt;p&gt;&lt;/p&gt;</description>
      <content:encoded>&lt;p&gt;Welcome to the ODX Andropause &amp;amp; Low T Syndrome Series. In this series of posts, the ODX Research team dives into Testosterone with an exploration of andropause and Low T Syndrome in our male patients.&lt;/p&gt; 
&lt;p&gt;&lt;/p&gt;  
&lt;img src="https://track-na2.hubspot.com/__ptq.gif?a=5340373&amp;amp;k=14&amp;amp;r=https%3A%2F%2F5340373.hs-sites-na2.com%2Fblog-old%2Fandropause-part-1-an-introduction&amp;amp;bu=https%253A%252F%252F5340373.hs-sites-na2.com%252Fblog-old&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <pubDate>Tue, 20 Jul 2021 23:40:02 GMT</pubDate>
      <guid>https://5340373.hs-sites-na2.com/blog-old/andropause-part-1-an-introduction</guid>
      <dc:date>2021-07-20T23:40:02Z</dc:date>
      <dc:creator>ODX Research</dc:creator>
    </item>
    <item>
      <title>GGT - Much More Than a Liver Enzyme</title>
      <link>https://5340373.hs-sites-na2.com/blog-old/ggt-much-more-than-a-liver-enzyme</link>
      <description>&lt;p&gt;GGT has historically been viewed as a liver enzyme and a clue to emerging hepatobiliary dysfunction. In this post, we present a wider view of GGT's role in identifying dysfunction and posit a new and updated optimal range.&lt;/p&gt;</description>
      <content:encoded>&lt;p&gt;GGT has historically been viewed as a liver enzyme and a clue to emerging hepatobiliary dysfunction. In this post, we present a wider view of GGT's role in identifying dysfunction and posit a new and updated optimal range.&lt;/p&gt;  
&lt;img src="https://track-na2.hubspot.com/__ptq.gif?a=5340373&amp;amp;k=14&amp;amp;r=https%3A%2F%2F5340373.hs-sites-na2.com%2Fblog-old%2Fggt-much-more-than-a-liver-enzyme&amp;amp;bu=https%253A%252F%252F5340373.hs-sites-na2.com%252Fblog-old&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <pubDate>Sat, 12 Jun 2021 01:39:50 GMT</pubDate>
      <guid>https://5340373.hs-sites-na2.com/blog-old/ggt-much-more-than-a-liver-enzyme</guid>
      <dc:date>2021-06-12T01:39:50Z</dc:date>
      <dc:creator>ODX Research</dc:creator>
    </item>
  </channel>
</rss>
